140 related articles for article (PubMed ID: 25527635)
1. Inhibition of the GTPase Rac1 mediates the antimigratory effects of metformin in prostate cancer cells.
Dirat B; Ader I; Golzio M; Massa F; Mettouchi A; Laurent K; Larbret F; Malavaud B; Cormont M; Lemichez E; Cuvillier O; Tanti JF; Bost F
Mol Cancer Ther; 2015 Feb; 14(2):586-96. PubMed ID: 25527635
[TBL] [Abstract][Full Text] [Related]
2. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
3. Denbinobin, a phenanthrene from Dendrobium nobile, impairs prostate cancer migration by inhibiting Rac1 activity.
Lu TL; Han CK; Chang YS; Lu TJ; Huang HC; Bao BY; Wu HY; Huang CH; Li CY; Wu TS
Am J Chin Med; 2014; 42(6):1539-54. PubMed ID: 25427623
[TBL] [Abstract][Full Text] [Related]
4. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
5. Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.
Caggia S; Chunduri H; Millena AC; Perkins JN; Venugopal SV; Vo BT; Li C; Tu Y; Khan SA
J Cell Physiol; 2018 Jan; 234(1):802-815. PubMed ID: 30078221
[TBL] [Abstract][Full Text] [Related]
6. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.
Sharma A; Mendonca J; Ying J; Kim HS; Verdone JE; Zarif JC; Carducci M; Hammers H; Pienta KJ; Kachhap S
Mol Oncol; 2017 Jun; 11(6):655-669. PubMed ID: 28371345
[TBL] [Abstract][Full Text] [Related]
7. Rac1 plays a role in CXCL12 but not CCL3-induced chemotaxis and Rac1 GEF inhibitor NSC23766 has off target effects on CXCR4.
Mills SC; Howell L; Beekman A; Stokes L; Mueller A
Cell Signal; 2018 Jan; 42():88-96. PubMed ID: 29050986
[TBL] [Abstract][Full Text] [Related]
8. HeLa human cervical cancer cell migration is inhibited by treatment with dibutyryl-cAMP.
Lee JW; Lee J; Moon EY
Anticancer Res; 2014 Jul; 34(7):3447-55. PubMed ID: 24982353
[TBL] [Abstract][Full Text] [Related]
9. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway.
Liu S; Yu M; He Y; Xiao L; Wang F; Song C; Sun S; Ling C; Xu Z
Hepatology; 2008 Jun; 47(6):1964-73. PubMed ID: 18506888
[TBL] [Abstract][Full Text] [Related]
10. Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence.
Lin KT; Gong J; Li CF; Jang TH; Chen WL; Chen HJ; Wang LH
Cancer Res; 2012 Jun; 72(12):3000-9. PubMed ID: 22659453
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
13. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
[TBL] [Abstract][Full Text] [Related]
14. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
15. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
16. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
17. Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1.
Ahmat Amin MKB; Shimizu A; Zankov DP; Sato A; Kurita S; Ito M; Maeda T; Yoshida T; Sakaue T; Higashiyama S; Kawauchi A; Ogita H
Oncogene; 2018 Oct; 37(40):5416-5434. PubMed ID: 29867202
[TBL] [Abstract][Full Text] [Related]
18. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
19. Rac1 activation driven by 14-3-3ζ dimerization promotes prostate cancer cell-matrix interactions, motility and transendothelial migration.
Goc A; Abdalla M; Al-Azayzih A; Somanath PR
PLoS One; 2012; 7(7):e40594. PubMed ID: 22808202
[TBL] [Abstract][Full Text] [Related]
20. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase.
Zuo Y; Shields SK; Chakraborty C
Biochem Biophys Res Commun; 2006 Dec; 351(2):361-7. PubMed ID: 17064663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]